Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation

Psychopharmacology

Volumn 203, Issue 2, 2009, Pages 453-459

  Jewett, David C ^a   Hahn, Thomas W ^a   Smith, Travis R ^a   Fiksdal, Britta L ^a   Wiebelhaus, Jason M ^a   Dunbar, Andrew R ^a   Filtz, Catherine R ^a   Novinska, Noah L ^a   Levine, Allen S ^b  

^a UNIVERSITY OF WISCONSIN EAU CLAIRE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Drug discrimination; Feeding; Food intake; Operant behavior; Rimonabant; Sibutramine

Indexed keywords

RIMONABANT; SIBUTRAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; FOOD DEPRIVATION; FOOD INTAKE; HUNGER; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TECHNIQUE;

ANIMALS; APPETITE DEPRESSANTS; CYCLOBUTANES; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; EATING; FOOD DEPRIVATION; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 62449173101     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1350-1     Document Type: Article

References (28)

1. 1) receptors Psychopharmacology (Berl) 132 104 106
2. M Brown C Bing P King L Pickavance D Heal J Wilding 2001 Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y Br J Pharmacol 132 1898 1904
3. WR Buckett PC Thomas GP Luscombe 1988 The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation Prog Neuropsychopharmacol Biol Psychiatry 12 575 584
4. G Colombo R Agabio G Diaz C Lobina R Reali GL Gessa 1998 Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci 63 PL113 PL117
5. RL Corwin WL Woolverton CR Schuster 1990 Effects of cholecystokinin, d-amphetamine and fenfluramine in rats trained to discriminate 3 from 22 hr of food deprivation J Pharmacol Exp Ther 253 720 728
6. C Gundlah KF Martin DJ Heal SB Auerbach 1997 In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor J Pharmacol Exp Ther 283 581 591
7. DL Hansen S Toubro MJ Stock IA Macdonald A Astrup 1998 Thermogenic effects of sibutramine in humans Am J Clin Nutr 68 1180 1186
8. DL Hansen S Toubro MJ Stock IA Macdonald A Astrup 1999 The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction Int J Obes Relat Metab Disord 23 1016 1024
9. D Hansen A Astrup S Toubro N Finer P Kopelman J Hilsted S Rossner W Saris L Van Gaal W James Goulder For The SSGM 2001 Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance Int J Obes Relat Metab Disord 25 496 501
10. 1 receptor antagonist reduces hunger, caloric intake, and body weight in overweight or obese men Obes Res 9 70
11. HC Jackson MC Bearham LJ Hutchins SE Mazurkiewicz AM Needham DJ Heal 1997 Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat Br J Pharmacol 121 1613 1618
12. HC Jackson AM Needham LJ Hutchins SE Mazurkiewicz DJ Heal 1997 Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat Br J Pharmacol 121 1758 1762
13. TU Järbe RJ Lamb S Lin A Makriyannis 2001 (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacology (Berl) 156 369 380
14. 1 receptor antagonist Psychopharmacology (Berl) 177 35 45
15. 1 receptor antagonist rimonabant in rats Psychopharmacology (Berl) 198 467 478
16. DC Jewett TW Lefever DP Flashinski MN Koffarnus CR Cameron DJ Hehli MK Grace AS Levine 2006 Intraparaventricular neuropeptide Y and ghrelin induce learned behaviors that report food deprivation in rats NeuroReport 17 733 737
17. CA Luque JA Rey 1999 Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity Ann Pharmacother 33 968 978
18. CA Luque JA Rey 2002 The discovery and status of sibutramine as an anti-obesity drug Eur J Pharmacol 440 119 128
19. 1 receptor antagonist SR141716A on the behavior of pigeons and rats Psychopharmacology (Berl) 124 315 322
20. 1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats Am J Physiol Regul Integr Comp Physiol 295 R67 R75
21. T Melis S Succu F Sanna A Boi A Argiolas MR Melis 2007 The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food Neurosci Lett 419 231 235
22. CL Ogden MD Carroll LR Curtin MA McDowell CJ Tabak KM Flegal 2006 Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 1549 1555
23. FX Pi-Sunyer LJ Aronne HM Heshmati J Devin J Rosenstock 2006 Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial JAMA 295 761 775
24. M Rinaldi-Carmona F Barth M Heaulme D Shire B Calandra C Congy S Martinez J Maruani G Neliat D Caput 1994 SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 240 244
25. 1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset Behav Pharmacol 9 179 181
26. M Weintraub A Rubio A Golik L Byrne ML Scheinbaum 1991 Sibutramine in weight control: a dose-ranging, efficacy study Clin Pharmacol Ther 50 330 337
27. JL Wiley RL Barrett J Lowe RL Balster BR Martin 1995 Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats Neuropharmacology 34 669 676
28. JL Wiley JA Lowe RL Balster BR Martin 1995 Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys J Pharmacol Exp Ther 275 1 6